QScreen AI Inc. News Releases

QScreen AI Appoints Former Union Pacific Vice President as Strategic Advisor to Drive Expansion into North American Rail and Transportation Markets

Wed, 29 Apr 2026 07:03:00 -0400

Veteran rail executive with 25 years of senior commercial relationships across North America's Class I railroads joins a platform that enables real-time identification of probable drug use from a camera without requiring blood, breath, or urine testing.Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening, today announces the appointment of José Humberto "Beto"...

QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone - Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths

Mon, 27 Apr 2026 06:53:00 -0400

Patent-protected QAI Platform identifies the probable drug class - alcohol, opioids, benzodiazepines, stimulants, or cannabis from physiological camera data and simultaneously administers CIWA-Ar, COWS, C-SSRS and 10 further validated clinical instruments in under seven minutes with no hardware and no IT project; former Director of Pentagon Joint Artificial Intelligence Center advancing commercial engagement across US correctional facilities and national defense installations; Canadian...

QScreen AI Announces Strategic Financing to Advance Commercialization Initiatives Across North America

Thu, 26 Feb 2026 17:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee wellness, is pleased to announce a non-brokered private placement. The Company intends to issue (the "Offering") of up to 10,000,000 units (each, a "Unit") at a price of C$0.05 per Unit, for aggregate gross proceeds to the Company of up to C$500,000.Each Unit will be comprised of one common share of...

QScreen AI Advances Structured Commercial Discussions Following Canadian Trade Mission to Mexico

Mon, 23 Feb 2026 07:00:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 23, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee wellness, today provided an update on its participation in the official Government of Canada Trade Mission to Mexico, reporting substantive commercialization discussions with senior institutional and enterprise stakeholders as part of its broader North American growth strategy.Building on its recent...

QScreen AI Advances Quantum-Inspired Optimization with U.S. Patent Filing; Gains National Spotlight on CBC

Tue, 17 Feb 2026 07:00:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 17, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee wellness, today announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO). Entitled "System, Method, and Robotic Platform for Quantum-Inspired Multi-Objective Optimization of Human-Governed Clinical Intake and Readiness Data Collection Under...

Qscreen AI Announces Strategic U.S. Engagement to Drive Innovation in Public Safety and Institutional Health

Mon, 09 Feb 2026 07:01:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 9, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), a pioneering leader in artificial intelligence enabled health and safety technology, is pleased to announce that it has entered into an independent contractor agreement with Global Frontier Advisors L.P. ("GFA"), effective January 30, 2026. GFA will receive a combination of equity-based along with performance-based compensation during the term of the agreement, subject to applicable...

Predictmedix AI Rebrands as QScreen AI Inc., (QAI) Harnessing Quantum-AI Synergy for Health Screening

Tue, 27 Jan 2026 07:01:00 -0500

Toronto, Ontario--(Newsfile Corp. - January 27, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP0) (formerly Predictmedix AI Inc.), a pioneering leader in artificial intelligence enabled health and safety technology, is pleased to announce that, further to its news releases of January 12, 2026, the Company has completed its name change to QScreen AI Inc. (the "Name Change").As a result of the Name Change the Company's common shares (the "Common Shares") are expected to start...

Predictmedix AI Inc. Selected by Canadian Government for Mexico Trade Mission, Led by Minister Dominic LeBlanc, to Drive Growth and High-Value Partnerships

Thu, 15 Jan 2026 07:03:00 -0500

Participation in Canada's official trade mission provides Predictmedix with exclusive, government-facilitated introductions to Mexican distributors, clients, and industry leaders, accelerating international market entry and revenue opportunities. Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), a pioneering leader in artificial intelligence-enabled health and safety technology, proudly...

Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare

Mon, 12 Jan 2026 07:11:00 -0500

Toronto, Ontario--(Newsfile Corp. - January 12, 2026) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), excited to announce its proposed name change to QScreen AI Inc., with a new ticker symbol QAI, subject to regulatory approval. This strategic rebranding underscores the Company's evolution into a premier healthcare innovator, uniquely positioned at the intersection of artificial intelligence, quantum-inspired computing, and data-driven health...

Predictmedix AI Inc - 2025 Year End Corporate Update

Wed, 17 Dec 2025 07:00:00 -0500

A Defining Year Positioning Predictmedix AI at the Convergence of Quantum, AI, and Healthcare Toronto, Ontario--(Newsfile Corp. - December 17, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company") concludes 2025 having delivered a year of disciplined execution across technology development, global investor engagement, and strategic advancement—positioning the Company for a pivotal growth phase in 2026 at the convergence of artificial...